OBJECTIVE: Type 1 diabetes is associated with an increased risk of atherosclerosis. Adiponectin serum levels correlate inversely with cardiovascular disease in adults. The aim of this study was to examine associations between arterial stiffness indices and serum adiponectin concentrations in children and adolescents with type 1 diabetes and to study the impact of metabolic control. SUBJECTS AND METHODS: We evaluated arterial stiffness, distensibility, and compliance in 93 children and adolescents with type 1 diabetes and correlated the data with clinical parameters and HbA1c levels. The control group comprised 85 matched healthy children. Serum levels of adiponectin in children with diabetes were measured by enzyme-linked immunoassay and correlated with arterial stiffness indices. RESULTS: Arterial stiffness was significantly increased in children and adolescents with type 1 diabetes (aged 13.0 +/- 3.8 yr) compared with matched healthy children (p = 0.03). Arterial stiffness was elevated in males with type 1 diabetes compared with females (p = 0.023). Arterial distensibility was significantly lower in children with diabetes compared with healthy controls (p = 0.025). Arterial stiffness, distensibility, and compliance did not correlate with diabetes duration, level of HbA1c, or serum cholesterol. Adiponectin concentrations in children and adolescents with diabetes were significantly elevated compared with normal values based on gender, age, and body mass index. We found no significant associations between arterial stiffness indices and adiponectin levels in children with type 1 diabetes. CONCLUSIONS: Children and adolescents with type 1 diabetes had increased arterial stiffness and reduced arterial distensibility and arterial compliance. However, no associations between arterial functional alterations and adiponectin concentrations were seen.
OBJECTIVE:Type 1 diabetes is associated with an increased risk of atherosclerosis. Adiponectin serum levels correlate inversely with cardiovascular disease in adults. The aim of this study was to examine associations between arterial stiffness indices and serum adiponectin concentrations in children and adolescents with type 1 diabetes and to study the impact of metabolic control. SUBJECTS AND METHODS: We evaluated arterial stiffness, distensibility, and compliance in 93 children and adolescents with type 1 diabetes and correlated the data with clinical parameters and HbA1c levels. The control group comprised 85 matched healthy children. Serum levels of adiponectin in children with diabetes were measured by enzyme-linked immunoassay and correlated with arterial stiffness indices. RESULTS: Arterial stiffness was significantly increased in children and adolescents with type 1 diabetes (aged 13.0 +/- 3.8 yr) compared with matched healthy children (p = 0.03). Arterial stiffness was elevated in males with type 1 diabetes compared with females (p = 0.023). Arterial distensibility was significantly lower in children with diabetes compared with healthy controls (p = 0.025). Arterial stiffness, distensibility, and compliance did not correlate with diabetes duration, level of HbA1c, or serum cholesterol. Adiponectin concentrations in children and adolescents with diabetes were significantly elevated compared with normal values based on gender, age, and body mass index. We found no significant associations between arterial stiffness indices and adiponectin levels in children with type 1 diabetes. CONCLUSIONS:Children and adolescents with type 1 diabetes had increased arterial stiffness and reduced arterial distensibility and arterial compliance. However, no associations between arterial functional alterations and adiponectin concentrations were seen.
Authors: T Schubert; F Santini; A F Stalder; J Bock; S Meckel; L Bonati; M Markl; S Wetzel Journal: AJNR Am J Neuroradiol Date: 2011-04-07 Impact factor: 3.825
Authors: Amy S Shah; Lawrence M Dolan; Abigail Lauer; Cralen Davis; Dana Dabelea; Stephen R Daniels; Richard F Hamman; Santica Marcovina; R Paul Wadwa; Elaine M Urbina Journal: J Pediatr Endocrinol Metab Date: 2012 Impact factor: 1.634
Authors: Robert Dalla Pozza; Andreas Beyerlein; Claude Thilmany; Claudia Weissenbacher; Heinrich Netz; Heinrich Schmidt; Susanne Bechtold Journal: Cardiovasc Diabetol Date: 2011-06-16 Impact factor: 9.951
Authors: Elaine M Urbina; Scott Isom; Ronny A Bell; Deborah A Bowlby; Ralph D'Agostino; Stephen R Daniels; Lawrence M Dolan; Giuseppina Imperatore; Santica M Marcovina; Anwar T Merchant; Kristi Reynolds; Amy S Shah; R Paul Wadwa; Dana Dabelea Journal: J Am Heart Assoc Date: 2019-06-19 Impact factor: 6.106
Authors: Evgenia Gourgari; Jeanette M Stafford; Ralph D'Agostino; Lawrence M Dolan; Jean M Lawrence; Amy Mottl; Catherine Pihoker; Elaine M Urbina; R Paul Wadwa; Dana Dabelea Journal: Ann Pediatr Endocrinol Metab Date: 2019-09-30
Authors: Rafael de Oliveira Alvim; Paulo Caleb Junior Lima Santos; Mariane Manso Musso; Roberto de Sá Cunha; José Eduardo Krieger; José Geraldo Mill; Alexandre Costa Pereira Journal: Diabetol Metab Syndr Date: 2013-08-21 Impact factor: 3.320